Quality Requirements for Medicinal Cannabis and Respective Products in the European Union – Status Quo
Planta Medica · 01.07.2023 · 89 (08) · 808-823
DOI: 10.1055/a-1808-9708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.07.2023. Verfasst von Markus Veit. Beteiligte Einrichtung: Alphatopics, Kaufering, Germany. Hauptthemen laut MEDLINE: Medical Marijuana, Plants, Medicinal. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Medicinal cannabis and respective products have been available in EU member states as single-patient prescriptions without regular marketing authorizations for a couple of years. The Netherlands was the first member state to realize this; in the meantime other member states have followed. Today, aside from the Netherlands, Germany is the most important market for such products. The regulatory framework for the approval of medicinal cannabis and its distribution to patients in the EU member states is, however, not harmonized at all, and there are distinct national regulations. Regarding the quality of such products, the general requirements for herbal medicinal products as defined in the European Pharmacopoeia, national pharmacopoeias, and the EMA guidance documents in place beside GMP requirements in the EU are applicable. However, for a couple of aspects, every EU member state follows its own interpretation of these requirements. To facilitate free distribution of such products between EU member states in future and to harmonize requirements for quality and GMP, an EU-wide approach is needed. As a first step, this should be realized by implementing monographs for cannabis medicinal products in the European Pharmacopoeia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Alphatopics, Kaufering, Germany.
Zitieren
APA
Veit, M. (2023). Quality Requirements for Medicinal Cannabis and Respective Products in the European Union – Status Quo. Planta Medica, 89(08), 808-823. https://doi.org/10.1055/a-1808-9708
Vancouver
Veit M. Quality Requirements for Medicinal Cannabis and Respective Products in the European Union – Status Quo. Planta Medica. 2023;89(08):808-823. doi:10.1055/a-1808-9708
BibTeX
@article{Veit2023,
author = {Veit, Markus},
title = {Quality Requirements for Medicinal Cannabis and Respective Products in the European Union – Status Quo},
journal = {Planta Medica},
year = {2023},
volume = {89},
number = {08},
pages = {808--823},
doi = {10.1055/a-1808-9708}
}
EUVIMED